More Immuron Limited news
Immuron LimitedASX: IMC

US DoD NMRC files IND application with FDA

May 11, 2022 at 5:04 AM EDT · Issued by Immuron Limited

Filed with ASX · May 11, 2022 at 5:04 AM EDT

On 6ix: 6ix.com/news/us-dod-nmrc-files-ind-application-with-fda

Immuron Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Immuron Limited on 6ix

Story so far

  • US DoD NMRC Reports Positive Response to VaccineNov 9, 2020

Earlier from Immuron

  • US DoD Uniformed Services University Clinical UpdateMay 9, 2022
  • Appointment of Mr Steven Lydeamore as Chef Executive OfficerMay 5, 2022
  • Immuron Q3 Global Sales up 216% YoYApr 27, 2022
  • Half Yearly Report and AccountsFeb 25, 2022
  • Response to ASX QueryJan 24, 2022

Later from Immuron

  • European Patent Notification on Drug Composition for CDIJul 6, 2022
  • North American Travelan Sales up 494%, Global sales up 431%Jul 10, 2022
  • Immuron Update on IMM-124E SARS-CoV-2 ResearchAug 18, 2022
  • IMC investment in leading gut health biotech Ateria HealthOct 13, 2022
  • Immuron completes strategic investment in Ateria HealthNov 15, 2022
All Immuron news releases↗

Follow Immuron into a list and get an email when it puts out news.

Follow Immuron
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer